United States Cutaneous Lymphoma Consortium recommendations for treatment of cutaneous lymphomas during the COVID-19 pandemic

John A Zic; Weiyun Ai; Oleg E Akilov; Joi B Carter; Madeleine Duvic; Francine Foss; Michael Girardi; Alejandro A Gru; Ellen Kim; Amy Musiek; Elise A Olsen; Stefan M Schieke; Michi Shinohara; Jasmine M Zain; Larisa J Geskin

doi:10.1016/j.jaad.2020.04.049

United States Cutaneous Lymphoma Consortium recommendations for treatment of cutaneous lymphomas during the COVID-19 pandemic

J Am Acad Dermatol. 2020 Aug;83(2):703-704. doi: 10.1016/j.jaad.2020.04.049. Epub 2020 Apr 16.

Authors

John A Zic¹, Weiyun Ai², Oleg E Akilov³, Joi B Carter⁴, Madeleine Duvic⁵, Francine Foss⁶, Michael Girardi⁷, Alejandro A Gru⁸, Ellen Kim⁹, Amy Musiek¹⁰, Elise A Olsen¹¹, Stefan M Schieke¹², Michi Shinohara¹³, Jasmine M Zain¹⁴, Larisa J Geskin¹⁵

Affiliations

¹ Department of Dermatology, Vanderbilt University Medical Center, Nashville, Tennessee. Electronic address: john.zic@vumc.org.
² Division of Hematology/Oncology, University of California San Francisco, San Francisco, California.
³ Department of Dermatology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania.
⁴ Department of Dermatology, Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire.
⁵ Department of Dermatology, MD Anderson Cancer Center, Houston, Texas.
⁶ Division of Hematology/Oncology, Yale-New Haven Medical Center, New Haven, Connecticut.
⁷ Department of Dermatology, Yale-New Haven Medical Center, New Haven, Connecticut.
⁸ Department of Pathology, University of Virginia School of Medicine, Charlottesville, Virginia.
⁹ Department of Dermatology, University of Pennsylvania Perelman Center for Advanced Medicine, Philadelphia, Pennsylvania.
¹⁰ Division of Dermatology, Washington University in Saint Louis, St Louis, Missouri.
¹¹ Department of Dermatology, Duke University School of Medicine, Durham, North Carolina.
¹² Department of Dermatology, University of Wisconsin-Madison, Madison, Wisconsin.
¹³ Department of Dermatology, University of Washington Medical Center, Seattle, Washington.
¹⁴ Division of Hematology and Hematopoietic Cell Transplantation, City of Hope Comprehensive Cancer Center, Duarte, California.
¹⁵ Department of Dermatology, Columbia University Irving Medical Center, New York, New York. Electronic address: ljg2145@cumc.columbia.edu.

No abstract available

Keywords: COVID-19; Sézary syndrome; cutaneous lymphoma; high-risk; mycosis fungoides.

MeSH terms

Antibiotics, Antineoplastic / therapeutic use
Antineoplastic Agents, Immunological / adverse effects
Betacoronavirus / immunology
Betacoronavirus / isolation & purification
COVID-19
Chemoradiotherapy / methods
Coronavirus Infections / diagnosis
Coronavirus Infections / immunology*
Coronavirus Infections / mortality
Coronavirus Infections / virology
Hematopoietic Stem Cell Transplantation / adverse effects
Home Care Services, Hospital-Based
Humans
Lymphoma, T-Cell, Cutaneous / complications
Lymphoma, T-Cell, Cutaneous / immunology
Lymphoma, T-Cell, Cutaneous / therapy*
Mycosis Fungoides / complications
Mycosis Fungoides / immunology
Mycosis Fungoides / therapy*
Pandemics
Patient Selection
Photopheresis
Pneumonia, Viral / diagnosis
Pneumonia, Viral / immunology*
Pneumonia, Viral / mortality
Pneumonia, Viral / virology
Risk Assessment
SARS-CoV-2
Severity of Illness Index
Sezary Syndrome / complications
Sezary Syndrome / immunology
Sezary Syndrome / therapy*
Skin Neoplasms / complications
Skin Neoplasms / immunology
Skin Neoplasms / therapy*
Telemedicine / methods
Ultraviolet Therapy
United States

Substances

Antibiotics, Antineoplastic
Antineoplastic Agents, Immunological

Grants and funding

UL1 TR001863/TR/NCATS NIH HHS/United States